“…A growing body of evidence from experimental (Moriarty et al, 2011; Cao et al, 2019) and cross-sectional (Van Der Leeuw et al, 2015; Ikram et al, 2019) studies suggests significant neurocognitive impairment, including deterioration in attention, memory, and executive function with chronic pain and certain NCPCs, as well as adverse neurostructural and neurofunctional changes paralleling those implicated in ADRD pathogenesis (Ng et al, 2018; Cao et al, 2019). Longitudinal studies from North America (Whitlock et al, 2017; van der Leeuw et al, 2018; Ezzati et al, 2019; Khalid et al, 2020), Europe (Veronese et al, 2018), and East Asia (Yang et al, 2016; Tzeng et al, 2018; Yamada et al, 2019) also suggest significant associations of chronic pain and certain NCPCs to subsequent deterioration in memory (Whitlock et al, 2017; van der Leeuw et al, 2018), accelerated cognitive decline (Whitlock et al, 2017), new onset cognitive impairment (Whitlock et al, 2017; van der Leeuw et al, 2018), and incident ADRD (Ezzati et al, 2019; Innes & Sambamoorthi, 2020; Khalid et al, 2020).…”